Dendritic cell vaccination in combination with docetaxel for patients with prostate cancer – a randomized phase II study

Subjects

Subjects :

Oncology
medicine.medical_specialty
business.industry
Phases of clinical research
02 engineering and technology
Hematology
Dendritic cell
021001 nanoscience & nanotechnology
medicine.disease
030226 pharmacology & pharmacy
Vaccination
03 medical and health sciences
Prostate cancer
0302 clinical medicine
Docetaxel
Internal medicine
Medicine
0210 nano-technology
business
medicine.drug

Details

ISSN :

09237534

Volume :

27

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........200b17dd119a16c09fff2875b05873d3

Full Text :

https://doi.org/10.1093/annonc/mdw378.39